Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- ACC Launches New Program to Improve HF CareThe ACC has launched a new program, Transform HF Care: New Horizons in Treatment, to educate clinicians on the latest advances, medications and interventions emerging in heart failure (HF) management and treatment.
- ACCEL Lite: ODYSSEY-HCM: Mavacamten in nHCMIn this interview, Matthew Martinez MD, FACC and Milind Y. Desai, MD, MBA, FACC discuss “ODYSSEY-HCM: Mavacamten in nHCM.â€
- ACC CardiaCast: Courtside with the Chair: CV Care of the Masters Athletes - Part 2This episode is Part 2 of CV Care of the Masters Athlete where Dr. Jonathan Kim continues the discussion with Drs. Eugene H. Chung, Ankit B. Shah, and Jeffrey J. Hsu on the cardiovascular (CV) care of the masters athlete.
- Top Posters at ACC Middle East 2025 Address High Non-HDL-C, RV Impairment, Flurpiridaz F 18 PET MPIAs the ACC Middle East 2025 Together With 16th Emirates Cardiac Society Conference winds down in Dubai, UAE, the three winners of the conference's abstract competition were announced and invited to present at ACC.26 in New Orleans, LA.
- Dual Antiplatelet Therapy May Reduce Stroke Risk After Valve-in-Valve TAVIWhen compared with single antiplatelet therapy (SAPT), dual antiplatelet therapy (DAPT) after valve-in-valve TAVI to treat surgical bioprosthesis dysfunction may be associated with a lower one-year stroke incidence, according to a study presented at the 46th National Congress GISE 2025...